UBS Cuts Omega Healthcare Investors (OHI) Price Target to $52

UBS has reaffirmed its Buy rating for Omega Healthcare Investors with a new price target of $52.00, a 14.04% upside from the current price.

By EarningsIQ Research Desk · Published Oct 16, 2026, 2:26 PM EDT

Reviewed by automated data checks against the source data. How we make and check alerts

UBS cut its price target on Omega Healthcare Investors, Inc. ($OHI) to $52 from $54 on October 13, 2026, and rates the stock "Buy".

Since the rating, $OHI is up 0.9% to date (from the $45.22 close on Oct 13, 2026).

OHI Omega Healthcare Investors, Inc.

$45.64 +6.99% year to date

Daily close · Oct 16, 2026

Key Points

On October 13, 2026, UBS reiterated its Buy rating for Omega Healthcare Investors, Inc. with a price target of $52.00, down from $54.00.
UBS's $52 price target implies 14.04% upside from Omega Healthcare Investors, Inc.'s ($OHI) current $45.60 share price.
As of October 16, 2026, Omega Healthcare shares traded recently around $45.60, which is about 12.3% below UBS's target.
The company is set to report its next earnings on November 3, 2026, after generating $1.26 billion in revenue over the last twelve months.

Get $OHI trade alerts by text

We text you when insiders, Congress or big funds trade $OHI. Free.

Not investment advice. EarningsIQ is not a registered investment adviser, and this automated Omega Healthcare Investors, Inc. alert may contain errors. Disclosures

UBS has reaffirmed its Buy rating for Omega Healthcare Investors, Inc. (NYSE: OHI) on October 13, 2026, setting a new price target of $52.00, down from $54.00. This rating suggests that UBS remains optimistic about the company's prospects despite lowering its target.

Other Institutional Activity in Omega Healthcare Investors

Several other institutional investors have also shown interest in Omega Healthcare. Blackrock Inc. grew its holdings by 1,350,415 shares, bringing its total to 38,551,916 shares worth about $1.76 billion. Vanguard Portfolio Management LLC added 105,783 shares, ending with 27,229,625 shares valued at approximately $1.24 billion. Cohen & Steers Inc. increased its stake significantly by 10,958,376 shares, totaling 22,936,053 shares worth about $1.05 billion. Conversely, State Street Corporation reduced its holdings slightly by 45,177 shares, now holding 14,527,955 shares valued at about $663 million.

Omega Healthcare Investors, Inc. Stock Down 2.3%

As of October 16, 2026, Omega Healthcare shares were trading recently around $45.60. This price is about 12.3% below UBS's new target of $52.00, reflecting a cautious outlook compared to Wall Street's broader ratings. The stock's performance will be important to watch as the company approaches its next earnings report.

12-month forecast

$OHI price target

Omega Healthcare Investors, Inc. daily closes and this analyst's $52 target. Not advice.

Recent Earnings

In its trailing twelve months, Omega Healthcare reported revenue of approximately $1.26 billion, with an impressive net margin of 68.1%. The company has also achieved a return on equity of 16.5%. Omega is set to announce its next earnings results on November 3, 2026.

Insider Buying and Selling at Omega Healthcare Investors, Inc.

Insider trading activity includes Chief Executive Officer C. Taylor Pickett, who purchased 20,000 shares at an average price of $43.14 on November 5, 2025, totaling about $862,856. Additionally, Chief Investment Officer Vikas Gupta bought 11,500 shares at an average price of $42.97 on November 6, 2025, valued at approximately $494,118. Director Lisa Egbuonu-Davis sold 2,500 shares on August 8, 2025, for around $100,394.

Analysts Set New Price Targets

On October 13, 2026, UBS maintained its Buy rating for Omega Healthcare Investors with a new price target of $52.00, down from $54.00. Meanwhile, Barclays and Mizuho have maintained ratings of Underweight and Neutral, respectively, with targets of $50.00 and $46.00. The consensus from analysts suggests a diverse outlook on the stock's potential performance.

About Omega Healthcare Investors

Omega Healthcare Investors, Inc. is a real estate investment trust (REIT) that focuses on the long-term healthcare sector, particularly skilled nursing and assisted living facilities. The company operates a diverse portfolio of assets primarily through triple-net lease agreements. With headquarters in Hunt Valley, Maryland, Omega is positioned to benefit from the growing demand for healthcare services in the U.S. and beyond.

Bottom Line

Investors should keep an eye on Omega Healthcare's upcoming earnings report on November 3, 2026, as it will provide further insights into the company's performance. UBS's recent rating reaffirms its confidence in Omega, despite the lowered price target, reflecting the mixed sentiment among analysts.